IL2 and melanoma: Cytokine therapy is the first immunotherapy used for cancer patients, with IFN-α and IL-2 approved by FDA as treatments for several malignant cancers, including lymphoma, hairy cell leukemia, melanoma and renal cell carcinoma [171,172,173,174,175].